BRIEF published on 10/14/2024 at 20:35, 1 year 8 months ago SOFTwarfare Introduces Zero Trust Identity Solution for JADC2 Cybersecurity Innovation Biometric Authentication Zero Trust Identity JADC2 Security Defense Operations
BRIEF published on 10/14/2024 at 20:35, 1 year 8 months ago SOFTwarfare présente une solution d'identité Zero Trust pour JADC2 Authentification Biométrique Identité Zero Trust Sécurité JADC2 Opérations De Défense Innovation En Matière De Cybersécurité
BRIEF published on 10/14/2024 at 20:10, 1 year 8 months ago Fitch Affirms Leonteq's 'BBB' Rating with Stable Outlook Market Risk Leonteq AG Credit Rating Fitch Ratings Investment Outlook
BRIEF published on 10/14/2024 at 20:10, 1 year 8 months ago Fitch confirme la notation « BBB » de Leonteq avec des perspectives stables Notation De Crédit Perspectives D'investissement Notation De Fitch Leonteq SA Risque De Marché
BRIEF published on 10/14/2024 at 19:50, 1 year 8 months ago Inventiva obtient l'approbation de l'AMF pour son prospectus de financement AMF Financement Médicaments Inventiva Stéatohépatite
BRIEF published on 10/14/2024 at 19:50, 1 year 8 months ago Inventiva obtains AMF approval for its financing prospectus AMF Funding Inventiva Steatohepatitis Drugs
BRIEF published on 10/14/2024 at 19:21, 1 year 8 months ago Ikonisys Enhances Financial Position Through Capital Increase Private Placement Capital Increase Cancer Detection Ikonisys Shareholder Expansion
BRIEF published on 10/14/2024 at 19:21, 1 year 8 months ago Ikonisys renforce sa position financière grâce à une augmentation de capital Placement Privé Augmentation De Capital Détection Du Cancer Ikonisys Élargissement De L'actionnariat
BRIEF published on 10/14/2024 at 19:20, 1 year 8 months ago Shelly Group Transitions to European Company Status Shareholders Shelly Group Stock Listing European Company Legal Conversion
BRIEF published on 10/14/2024 at 19:20, 1 year 8 months ago Shelly Group devient une société européenne Actionnaires Société Européenne Groupe Shelly Conversion Juridique Cotation Des Actions
Published on 06/26/2026 at 14:05, 2 hours 14 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 2 hours 19 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 3 hours 19 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 3 hours 34 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:30, 48 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 55 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 15:23, 56 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/26/2026 at 07:00, 9 hours 19 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 9 hours 19 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
